Marco Gerlinger (@marcogerlinger) 's Twitter Profile
Marco Gerlinger

@marcogerlinger

Medical Oncologist and Clinician Scientist working on GI Cancer Genomics/Cancer Evolution, Immunotherapies and Biomarkers

ID: 2867024187

linkhttp://www.icr.ac.uk/our-research/researchers-and-teams/dr-marco-gerlinger calendar_today08-11-2014 08:43:40

374 Tweet

1,1K Followers

93 Following

Marco Gerlinger (@marcogerlinger) 's Twitter Profile Photo

“Understanding immune evasion and suppression in colon cancer liver mets through single cell sequencing” Exciting PhD opportunity in my lab at the Barts Cancer Institute: check details and apply here: bartscancer.london/about/vacancie…

Marco Gerlinger (@marcogerlinger) 's Twitter Profile Photo

-Parallel evolution which surpasses even that in RCC! -Big headache for biomarker development! Our study on ITH in dMMR CRCs is out: bit.ly/3SHtxjX High mutation supply and strong immune selection pressures make this a great model tumor for #CancerEvo studies

Marco Gerlinger (@marcogerlinger) 's Twitter Profile Photo

It’s a great honour to be part of the Colorectal Cancer Alliance inaugural #CureCRCsummit this week. Brainstorming strategies to cure #colorectal cancer with giants in the field Drs Scott Kopetz, Batlle, Venook, Lenz, Myriam Chalabi, Andrea Cercek + many others

It’s a great honour to be part of the <a href="/CCAlliance/">Colorectal Cancer Alliance</a> inaugural #CureCRCsummit this week. Brainstorming strategies to cure #colorectal cancer with giants in the field Drs <a href="/skopetz/">Scott Kopetz</a>, Batlle, Venook, Lenz, <a href="/MyriamChalabi/">Myriam Chalabi</a>, <a href="/AndreaCercek/">Andrea Cercek</a> + many others
Barts Cancer Institute (Queen Mary) (@qmbci) 's Twitter Profile Photo

We're delighted that Prof Tom Powles (Tom Powles) has been selected as one of nature's 10 people who shaped science for his transformative clinical work delivering a life-extending treatment for severe bladder cancer. A huge honour – congratulations to Tom and his team 👏👏👏

Myriam Chalabi (@myriamchalabi) 's Twitter Profile Photo

What a great start of 2024! Excited, happy and proud to share our latest work published today #openaccess Nature Medicine on the PANDA trial: neoadjuvant atezo+chemo in pts with gastric/GEJ cancers followed by surgery. Some of the key findings below. 1/10 nature.com/articles/s4159…

What a great start of 2024! Excited, happy and proud to share our latest work published today #openaccess <a href="/NatureMedicine/">Nature Medicine</a> on the PANDA trial: neoadjuvant atezo+chemo in pts with gastric/GEJ cancers followed by surgery. Some of the key findings below. 1/10 nature.com/articles/s4159…
Yale Cancer Center (@yalecancer) 's Twitter Profile Photo

.@politikaterina will be presenting during the Lineage Plasticity in Tumor Evolution and Acquired Resistance educational session at #AACR24, this morning at 8am PST/11am EST. abstractsonline.com/pp8/#!/20272/s… Smilow Cancer Hospital Yale School of Medicine Yale New Haven Hosp Yale Pathology Yale Thoracic Surgery

.@politikaterina will be presenting during the Lineage Plasticity in Tumor Evolution and Acquired Resistance educational session at #AACR24, this morning at 8am PST/11am EST.
abstractsonline.com/pp8/#!/20272/s…
<a href="/SmilowCancer/">Smilow Cancer Hospital</a> <a href="/YaleMed/">Yale School of Medicine</a> <a href="/YNHH/">Yale New Haven Hosp</a> <a href="/yalepathology/">Yale Pathology</a> <a href="/YaleThoracic/">Yale Thoracic Surgery</a>
Charles Swanton (@charlesswanton) 's Twitter Profile Photo

What is the role of the TME in lung cancer evolution? We are excited to share our new TRACERx paper “Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer” at #AACR24, out in Cancer Discovery today rb.gy/q484j9 Tweetorial👇

What is the role of the TME in lung cancer evolution? We are excited to share our new TRACERx paper “Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer” at #AACR24, out in <a href="/CD_AACR/">Cancer Discovery</a> today rb.gy/q484j9 Tweetorial👇
Marco Gerlinger (@marcogerlinger) 's Twitter Profile Photo

Important POSTER SESSIONS For those of you at #AACR24: 👉🏻Tumor Evolution in Space and Time is on Monday 9am-12:30 (section 12) 👉🏻Tumor Evolution Models and Technologies on Tuesday 9am-12:30 (section 13) We received 🏅outstanding 🥇 abstracts this year. Don‘t miss out!!

Important POSTER SESSIONS For those of you at #AACR24:
👉🏻Tumor Evolution in Space and Time is on Monday 9am-12:30 (section 12)
👉🏻Tumor Evolution Models and Technologies on Tuesday 9am-12:30 (section 13)
We received 🏅outstanding 🥇 abstracts this year. Don‘t miss out!!
Yale Cancer Center (@yalecancer) 's Twitter Profile Photo

.Jeffrey Townsend discussed how the evolution of #cancer is rarely linear, but a branching model that influences progression #AACR24 “Every one of our bodies has a tree of history underlying every cell in our body.” #phylogenetics AACR Smilow Cancer Hospital Yale School of Medicine Yale School of Public Health

.<a href="/JeffTownsend/">Jeffrey Townsend</a> discussed how the evolution of #cancer is rarely linear, but a branching model that influences progression #AACR24 “Every one of our bodies has a tree of history underlying every cell in our body.” #phylogenetics <a href="/AACR/">AACR</a> <a href="/SmilowCancer/">Smilow Cancer Hospital</a> <a href="/YaleMed/">Yale School of Medicine</a> <a href="/YaleSPH/">Yale School of Public Health</a>
Marco Gerlinger (@marcogerlinger) 's Twitter Profile Photo

Outstanding session with @elena_elez and @BenjcRousseau on immunotherapy biomarkers at ASCO #ASCO24 this morning. Key messages: Exciting and powerful new IO biomarkers on the horizon. We now need to apply them to large clinical trials including those from industry.

Outstanding session with @elena_elez and @BenjcRousseau on immunotherapy biomarkers at <a href="/ASCO/">ASCO</a> #ASCO24 this morning. Key messages: Exciting and powerful new IO biomarkers on the horizon. We now need to apply them to large clinical trials including those from industry.
St Bartholomew's Hospital GI Cancer Centre (@bartsgi_cancer) 's Twitter Profile Photo

Kickoff meeting of our new St Barts Hospital - Fudan University Cancer Centre Oesophageal Cancer Research Collaboration in Shanghai today and yesterday. Very grateful to @RoyalSociary for funding this project which is led by Prof Marco Gerlinger and Prof Zhen Zhang

Kickoff meeting of our new St Barts Hospital - Fudan University Cancer Centre Oesophageal Cancer Research Collaboration in Shanghai today and yesterday. Very grateful to @RoyalSociary for funding this project which is led by Prof <a href="/MarcoGerlinger/">Marco Gerlinger</a> and Prof Zhen Zhang
Hongcheng Zhu 祝鸿程 (@drhongchengzhu) 's Twitter Profile Photo

Starting from International Exchange Award between UK and China supported by The Royal Society, more exciting opportunities have been discussed for collaboration in clinical and translational research between the two premier centers in London and Shanghai 🇬🇧🇨🇳

Starting from International Exchange Award between UK and China supported by <a href="/royalsociety/">The Royal Society</a>, more exciting opportunities have been discussed for collaboration in clinical and translational research between the two premier centers in London and Shanghai 🇬🇧🇨🇳
Marco Gerlinger (@marcogerlinger) 's Twitter Profile Photo

Touched down in Miami for the 2024 Colorectal Cancer Alliance #CureCRC Summit - very exciting to be here again to help make this cancer history. Well prepared after lovely Christmas dinner and afternoon tea (‼️‼️) on board of the A380 💪💪💪

Marco Gerlinger (@marcogerlinger) 's Twitter Profile Photo

Join the discussion: Pervasive Cellular Plasticity intertwined with Darwinian Evolution in Cancer - does this need a new Evolutionary Theory? See our review just out in Trends in Cancer sciencedirect.com/science/articl…

Join the discussion: Pervasive Cellular Plasticity intertwined with Darwinian Evolution in Cancer - does this need a new Evolutionary Theory? See our review just out in <a href="/trendscancer/">Trends in Cancer</a> sciencedirect.com/science/articl…
Marco Gerlinger (@marcogerlinger) 's Twitter Profile Photo

Still time to register for our free AACR IO webinar today: “Tumour Mutation Burden, Heterogeneity and Immunotherapy Efficacy”with Profs Jaffe, Quezada and Wargo aacr.org/meeting/aacr-i…

Marco Gerlinger (@marcogerlinger) 's Twitter Profile Photo

🔥Just opened: 4 year CLINICAL LECTURERSHIP position in HISTOPATHOLOGY Barts Health and my lab Barts Cancer Institute (Queen Mary) in London: for ST3/4 registrars who already hold a PhD/MD. Great opportunity for a deep dive into the immunobiology of MMRd cancer. Deadline 11/04 10am oriel.nhs.uk/Web/Vacancy/Va…